---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-124150"
form_type: "8-K/A"
ticker: "ASNS"
cik: "0001141284"
company_name: "ACTELIS NETWORKS INC"
filed_at: "2025-12-22T23:59:59+00:00"
generated_at: "2026-05-16T12:23:31.148325+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Actelis amends 8-K to state offering proceeds for general corporate purposes

## Summary
- Amendment revises prior 8-K (Dec 17, 2025); proceeds now for general corporate purposes not R&D.
- Original 8-K stated proceeds intended for pre-clinical/clinical studies; amended to match press release.
- No other changes to the original 8-K or its exhibits; filing date December 22, 2025.
- Company ticker ASNS; CEO Tuvia Barlev signed the amendment.

## SEC filing metadata
- accession: 0001213900-25-124150
- form_type: 8-K/A
- ticker: ASNS
- cik: 0001141284
- company_name: ACTELIS NETWORKS INC
- filed_at: 2025-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1141284/000121390025124150/0001213900-25-124150-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1141284/000121390025124150/ea0270510-8ka1_actelis.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-124150
- JSON: https://secwatch.observer/filing/0001213900-25-124150.json
- Plain text: https://secwatch.observer/filing/0001213900-25-124150.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.